Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QPT

Stimulator, Tibial, Electrical, Implantable, For Urinary Incontinence

Implanted electrical stimulator, including implanted power source, for treatment of overactive bladder or symptoms of overactive bladder through electrical stimulation of the tibial nerve.

Product / regulatory recordCompanyPathwayDecision dateSource
AltavivaP240011/S016
Medtronic NeuromodulationPMA supplementSep 14, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementSep 9, 2026FDA
AltavivaP240011/S015
Medtronic NeuromodulationPMA supplementAug 14, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementJul 20, 2026FDA
AltavivaP240011/S010
Medtronic NeuromodulationPMA supplementJul 13, 2026FDA
AltavivaP240011/S014
Medtronic NeuromodulationPMA supplementJun 16, 2026FDA
AltavivaP240011/S013
Medtronic NeuromodulationPMA supplementMay 13, 2026FDA
AltavivaP240011/S012
Medtronic NeuromodulationPMA supplementApr 3, 2026FDA
AltavivaP240011/S011
Medtronic NeuromodulationPMA supplementMar 26, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementMar 3, 2026FDA
AltavivaP240011/S008
Medtronic NeuromodulationPMA supplementFeb 27, 2026FDA
Medtronic NeuromodulationPMA supplementFeb 12, 2026FDA
Medtronic NeuromodulationPMA supplementFeb 6, 2026FDA
AltavivaP240011/S005
Medtronic NeuromodulationPMA supplementJan 14, 2026FDA
Medtronic NeuromodulationPMA supplementDec 19, 2025FDA
AltavivaP240011/S003
Medtronic NeuromodulationPMA supplementNov 26, 2025FDA
Medtronic NeuromodulationPMA supplementOct 21, 2025FDA
Medtronic NeuromodulationPMA supplementOct 17, 2025FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementOct 2, 2025FDA
Medtronic NeuromodulationPMA approvalSep 18, 2025FDA
BOSTON SCIENTIFIC CORPORATIONPMA approvalMar 1, 2022FDA
Source information

Follow the FDA links to view the original records.

All device categories